Effect of Music on Reading Comprehension in Patients With Aphasia

NCT03600987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2020-01-06

No results posted yet for this study

Summary

The purpose of this investigation is to examine the evidence on emotion, language, and music, and propose a first step, in the form of a single-subject research design, to determine the most effective and efficient method for application to the rehabilitation of patients with aphasia. A single-subject adapted alternating treatment design will be used to compare two music conditions, using music with sung lyrics simultaneously with reading of the lyrics, and priming with music and sung lyrics followed by a reading of the lyrics, with a control condition using reading lyrics without music. Results are expected to provide evidence of independent versus shared processing of music and language at the phrase level applied to the behavior of human subjects with aphasia.

Conditions

  • Aphasia

Interventions

BEHAVIORAL

Simultaneous music and reading lyrics

listening to music with singing of the lyrics simultaneously with reading the written lyrics.

BEHAVIORAL

Priming with music

priming by listening to music and singing of the lyrics followed by reading the written lyrics.

BEHAVIORAL

Control

control condition using reading materials without music.

Sponsors & Collaborators

  • Carilion Clinic

    lead OTHER

Principal Investigators

  • Jacqueline A. Treichler · Carilion Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-18
Primary Completion
2019-10-17
Completion
2019-10-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600987 on ClinicalTrials.gov